The arrhythmogenic substrate--diagnostic and therapeutic implications: hypertrophic cardiomyopathy

A K Slade1, R C Saumarez, W J McKenna

  • 1Department of Cardiological Sciences, St. Georges Hospital Medical School, Tooting, London, U.K.

European Heart Journal
|September 1, 1993
PubMed

Insights

Hypertrophic cardiomyopathy is a key model for sudden cardiac death research. A new electrophysiological technique shows promise for better risk stratification in these patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Hypertrophic cardiomyopathy serves as a critical model for understanding sudden cardiac death mechanisms.
  • Potential triggers for sudden cardiac death include sinus tachycardia and paroxysmal supraventricular arrhythmias.
  • Patient-specific factors like exercise hemodynamics and autonomic function influence the impact of these triggers.

Purpose of the Study:

  • To explore the underlying mechanisms of sudden cardiac death in hypertrophic cardiomyopathy.
  • To evaluate the effectiveness of current risk stratification methods for sudden cardiac death.
  • To introduce and assess a novel electrophysiological technique for improved risk assessment.

Main Methods:

  • Review of existing literature on hypertrophic cardiomyopathy and sudden cardiac death.
  • Analysis of conventional risk factors and non-invasive techniques (e.g., Holter monitoring).
  • Evaluation of conventional electrophysiological methods like programmed ventricular stimulation.
  • Description of a novel electrophysiological technique.

Main Results:

  • Conventional methods and risk factors often fail to accurately stratify sudden cardiac death risk.
  • Programmed ventricular stimulation has limited utility, often inducing non-specific arrhythmias.
  • The novel electrophysiological technique presents a more promising approach for risk stratification.

Conclusions:

  • Accurate risk stratification for sudden cardiac death in hypertrophic cardiomyopathy remains a challenge.
  • Existing electrophysiological methods have limitations in predicting lethal arrhythmias.
  • The novel electrophysiological technique warrants further investigation for its potential to improve patient outcomes.

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...